2021 American Transplant Congress
Offer Acceptance Models for Various Endpoints: Initial Response, Final Response, and Conversion from Provisional Yes to Yes
United Network for Organ Sharing, Richmond, VA
*Purpose: Offer acceptance models are routinely used for program evaluation and academic research, but the focus tends to be on modelling the final offer response.…2021 American Transplant Congress
Clinical Analysis of the Prognosis After Receiving a Liver Graft That Abandoned Transplantation Due to Poor Graft Conditions in the Centers Allocated as a Priority
*Purpose: LT has the limitation of lack of donors compared to those waiting for a transplant. Depending on the recipient's condition, even liver grafts with…2021 American Transplant Congress
Outcomes of Simultaneous Kidney-Pancreas Transplantation in Patients with Type-I and Type-II Diabetes Mellitus
*Purpose: UNOS approved simultaneous kidney-pancreas transplantation (SKPT) for type-II diabetes mellitus (DM) in Oct 2014. There is limited data comparing outcomes of SKPT in type-I…2021 American Transplant Congress
Geographic Divergence in Waitlist Registration and Trends in Waitlist Removal for Liver Transplantation in Patients with Nonalcoholic Steatohepatitis (NASH)
*Purpose: This study aims to evaluate regional trends of waitlist (WL) registrations and removal for liver transplantation (LT) among United States (US) adults listed for…2021 American Transplant Congress
Waitlist Outcomes for Exception Candidates Following the Implementation of MMaT/250 Score
1Johns Hopkins Medical Institutions, Baltimore, MD, 2Temple University, Philadelphia, PA
*Purpose: Starting in May 2019, exception points were allocated based on DSA-level median-MELD-at-transplant (MMaT/DSA). In February 2020, the exception point system was further modified based…2021 American Transplant Congress
Albumin Level Prior to Liver-Directed Therapy is a Risk Factor of Waitlist Tumor Progression Independent of HCC Burden
Ochsner Health, New Orleans, LA
*Purpose: Milan Criteria, α-fetoprotein (AFP), and MELD score at diagnosis influence prognosis in bridge to transplant (BTT) hepatocellular carcinoma (HCC). With HCC surveillance many patients…2021 American Transplant Congress
Improving Liver Transplantation Outcomes for Hepatitis C Associated Hepatocellular Carcinoma in Direct-Acting Antiviral Therapy Era
Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY
*Purpose: Direct-acting antiviral (DAA) therapy has transformed the outcomes of liver transplantation(LT) in patients with hepatitis C virus (HCV). The aim of this study was…2021 American Transplant Congress
Admission to the Intensive Care Unit Post-liver Transplantation: One Academic Center’s Experience
Transplant Critical Care, Mayo Clinic, Jacksonville, FL
*Purpose: Historically, liver transplant (LT) patients have been admitted directly from the operating room (OR) to the intensive care unit (ICU) for post-operative complex hemodynamic…2021 American Transplant Congress
Center Cost is Not a Barrier to Aggressive Utilization of DCD Livers
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Only 7% of livers transplanted in 2018 were from deceased from cardiac death (DCD) donors and only a minority of transplant centers aggressively utilize…2021 American Transplant Congress
Liver Simulated Allocation Model (LSAM) of a Height-Based Policy Change to Improve Sex Disparity in Liver Transplantation (LT)
1UCSF, SF, CA, 2City U, HK, Hong Kong, 3CMU, Pittsburgh, PA
*Purpose: Since the introduction of the MELD-based allocation system, women are now 30% less likely than men to undergo LT and have 20% higher waitlist…
- « Previous Page
- 1
- …
- 216
- 217
- 218
- 219
- 220
- …
- 1683
- Next Page »